Literature DB >> 8489485

Catecholamines and essential hypertension.

M D Esler1.   

Abstract

Given the ubiquitous distribution of catecholamines in mammals, and their importance in a range of physiological processes pivotal to blood pressure regulation, the subject of catecholamines and essential hypertension has a broader context than simply consideration of sympathetic nervous system and adrenal medullary dysfunction. These further matters are the likely involvement in hypertension pathogenesis of the CNS catecholaminergic neurones influencing peripheral sympathetic outflow, the possible pathogenetic significance of adrenaline released as a cotransmitter in sympathetic nerves, and the natriuretic renal tubular dopamine mechanisms for regulating body sodium balance which appear to be impaired in patients with essential hypertension. The central consideration, however, remains the important issue of the causes and consequences of the now well-documented sympathetic nervous overactivity which characterizes the early developmental phases of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489485     DOI: 10.1016/s0950-351x(05)80182-x

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  4 in total

Review 1.  Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes.

Authors:  A J M Verberne; W S Korim; A Sabetghadam; I J Llewellyn-Smith
Journal:  Br J Pharmacol       Date:  2016-03-08       Impact factor: 8.739

2.  Tannic acid down-regulates the angiotensin type 1 receptor through a MAPK-dependent mechanism.

Authors:  Rekha Yesudas; Upendra Gumaste; Russell Snyder; Thomas Thekkumkara
Journal:  Mol Endocrinol       Date:  2012-02-09

3.  Interplay between EGR1 and SP1 is critical for 13-cis retinoic acid-mediated transcriptional repression of angiotensin type 1A receptor.

Authors:  Russell Snyder; Thomas Thekkumkara
Journal:  J Mol Endocrinol       Date:  2013-04-23       Impact factor: 5.098

4.  Association of Catechol-O-methyltransferase (COMT Val158Met) with future risk of cardiovascular disease in depressed individuals - a Swedish population-based cohort study.

Authors:  Aysha Almas; Yvonne Forsell; Vincent Millischer; Jette Möller; Catharina Lavebratt
Journal:  BMC Med Genet       Date:  2018-07-25       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.